Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study
- 393 Downloads
Few population-based studies have focused on cardiovascular disease (CVD) risk in adolescent and young adult (AYA; 15–39 years) cancer survivors and none have considered whether CVD risk differs by sociodemographic factors.
Analyses focused on 79,176 AYA patients diagnosed with 14 first primary cancers in 1996–2012 and surviving > 2 years after diagnosis with follow-up through 2014. Data were obtained from the California Cancer Registry and State hospital discharge data. CVD included coronary artery disease, heart failure, and stroke. The cumulative incidence of developing CVD accounted for the competing risk of death. Multivariable Cox proportional hazards regression evaluated factors associated with CVD and the impact of CVD on mortality.
Overall, 2249 (2.8%) patients developed CVD. Survivors of central nervous system cancer (7.3%), acute lymphoid leukemia (6.9%), acute myeloid leukemia (6.8%), and non-Hodgkin lymphoma (4.1%) had the highest 10-year CVD incidence. In multivariable models, African-Americans (hazard ratio (HR) = 1.55, 95% confidence interval (CI) = 1.33–1.81; versus non-Hispanic Whites), those with public/no health insurance (HR = 1.78, 95% CI = 1.61–1.96; versus private) and those who resided in lower socioeconomic status neighborhoods had a higher CVD risk. These sociodemographic differences in CVD incidence were apparent across most cancer sites. The risk of death was increased by eightfold or higher among AYAs who developed CVD.
While cancer therapies are known to increase the risk of CVD, this study additionally shows that CVD risk varies by sociodemographic factors.
Implications for cancer survivors
The identification and mitigation of CVD risk factors in these subgroups may improve long-term patient outcomes.
KeywordsCancer Cardiovascular diseases Insurance Adolescent Young adult Race/ethnicity Socioeconomic factors
This work was supported by the Rich and Weissman Family Lymphoma and Survivorship Fund St. Baldrick’s Research Grant. Dr. Wun’s effort also supported by National Center for Advancing Translational Sciences TR000002. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention’s National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California, Department of Public Health the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study did not involve interactions with human subjects and was considered exempt (category 4) by the Institutional Review Board of the University of California, Davis.
- 1.Nass SJ, Beaupin LK, Demark-Wahnefried W, Fasciano K, Ganz PA, Hayes-Lattin B, et al. Identifying and addressing the needs of adolescents and young adults with cancer: summary of an institute of medicine workshop. Oncologist. 2015;20(2):186–95. https://doi.org/10.1634/theoncologist.2014-0265.CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Scholz-Kreisel P, Spix C, Blettner M, Eckerle S, Faber J, Wild P, et al. Prevalence of cardiovascular late sequelae in long-term survivors of childhood cancer: a systematic review and meta-analysis. Pediatr Blood Cancer. 2017;64(7) https://doi.org/10.1002/pbc.26428.
- 3.Chao C, Xu L, Bhatia S, Cooper R, Brar S, Wong FL, et al. Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the Kaiser Permanente AYA cancer survivors study. J Clin Oncol. 2016;34(14):1626–33. https://doi.org/10.1200/JCO.2015.65.5845.CrossRefPubMedGoogle Scholar
- 7.Henson KE, Reulen RC, Winter DL, Bright CJ, Fidler MM, Frobisher C, et al. Cardiac mortality among 200,000 five-year survivors of cancer diagnosed at 15 to 39 years of age: the teenage and young adult cancer survivor study. Circulation. 2016;134(20):1519–31. https://doi.org/10.1161/CIRCULATIONAHA.116.022514.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Bright CJ, Hawkins MM, Guha J, Henson KE, Winter DL, Kelly JS, et al. Risk of cerebrovascular events in 178 962 five-year survivors of cancer diagnosed at 15 to 39 years of age: the TYACSS (Teenage and Young Adult Cancer Survivor Study). Circulation. 2017;135(13):1194–210. https://doi.org/10.1161/CIRCULATIONAHA.116.025778.CrossRefPubMedGoogle Scholar
- 9.Derouen MC, Gomez SL, Press DJ, Tao L, Kurian AW, Keegan TH. A population-based observational study of first-course treatment and survival for adolescent and young adult females with breast cancer. J Adolesc Young Adult Oncol. 2013;2(3):95–103. https://doi.org/10.1089/jayao.2013.0004.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Kent EE, Morris RA, Largent JA, Ziogas A, Sender LS, Anton-Culver H. Socioeconomic impacts on survival differ by race/ethnicity among adolescents and young adults with non-Hodgkin’s lymphoma. J Cancer Epidemiol. 2010;2010:824691. https://doi.org/10.1155/2010/824691.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Keegan TH, DeRouen MC, Parsons HM, Clarke CA, Goldberg D, Flowers CR, et al. Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: a population-based study. Cancer Epidemiol Biomark Prev. 2016;25(2):264–73. https://doi.org/10.1158/1055-9965.EPI-15-0756.CrossRefGoogle Scholar
- 17.Parsons HM, Schmidt S, Harlan LC, Kent EE, Lynch CF, Smith AW, et al. Young and uninsured: insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study. Cancer. 2014;120(15):2352–60. https://doi.org/10.1002/cncr.28685.CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Chao C, Chiu V, Mueller LA, Cooper R. Exploring the feasibility of establishing a retrospective cohort of survivors of adolescent and young adult cancer to study long-term health outcomes in an integrated managed care environment. J Adolesc Young Adult Oncol. 2013;2(2):59–65. https://doi.org/10.1089/jayao.2012.0024.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Lin G, So Y, Johnston G. Analyzing survival data with competing risks using SAS® software. Cary: SAS Institute Inc; 2012.Google Scholar
- 26.Russell RR, Alexander J, Jain D, Poornima IG, Srivastava AV, Storozynsky E, et al. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. J Nucl Cardiol. 2016;23(4):856–84. https://doi.org/10.1007/s12350-016-0538-8.CrossRefPubMedGoogle Scholar
- 29.Rotz SJ, Ryan TD, Hlavaty J, George SA, El-Bietar J, Dandoy CE. Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant. Pediatr Blood Cancer. 2017;64(11) https://doi.org/10.1002/pbc.26600.
- 38.Berkman AM, Brewster AM, Jones LW, Yu J, Lee JJ, Peng SA, et al. Racial differences in 20-year cardiovascular mortality risk among childhood and young adult cancer survivors. J Adolesc Young Adult Oncol. 2017; https://doi.org/10.1089/jayao.2017.0024.
- 39.Centers for Disease Control and Prevention. Coronary heart disease and stroke deaths—United States, 2009. MMWR. 2013;62(Suppl 3):157–60.Google Scholar
- 40.Schootman M, Deshpande AD, Pruitt SL, Aft R, Jeffe DB. National estimates of racial disparities in health status and behavioral risk factors among long-term cancer survivors and non-cancer controls. Cancer Causes Control. 2010;21(9):1387–95. https://doi.org/10.1007/s10552-010-9566-x.CrossRefPubMedPubMedCentralGoogle Scholar
- 41.White A, Pollack LA, Smith JL, Thompson T, Underwood JM, Fairley T. Racial and ethnic differences in health status and health behavior among breast cancer survivors—behavioral risk factor surveillance system, 2009. J Cancer Surviv. 2013;7(1):93–103. https://doi.org/10.1007/s11764-012-0248-4.CrossRefPubMedGoogle Scholar
- 42.Ness KK, Leisenring WM, Huang S, Hudson MM, Gurney JG, Whelan K, et al. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer. 2009;115(9):1984–94. https://doi.org/10.1002/cncr.24209.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Liu Q, Leisenring WM, Ness KK, Robison LL, Armstrong GT, Yasui Y, et al. Racial/ethnic differences in adverse outcomes among childhood cancer survivors: the childhood cancer survivor study. J Clin Oncol. 2016;34(14):1634–43. https://doi.org/10.1200/JCO.2015.66.3567.CrossRefPubMedPubMedCentralGoogle Scholar
- 44.Landier W, Chen Y, Namdar G, Francisco L, Wilson K, Herrera C, et al. Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors. J Clin Oncol. 2015;33(33):3887–93. https://doi.org/10.1200/JCO.2015.62.7562.CrossRefPubMedPubMedCentralGoogle Scholar
- 46.Kanjilal S, Gregg EW, Cheng YJ, Zhang P, Nelson DE, Mensah G, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med. 2006;166(21):2348–55. https://doi.org/10.1001/archinte.166.21.2348.CrossRefPubMedGoogle Scholar
- 47.Odutayo A, Gill P, Shepherd S, Akingbade A, Hopewell S, Tennankore K, et al. Income disparities in absolute cardiovascular risk and cardiovascular risk factors in the United States, 1999-2014. JAMA Cardiol. 2017;2(7):782–90. https://doi.org/10.1001/jamacardio.2017.1658.CrossRefPubMedPubMedCentralGoogle Scholar